Loading…
Lobbying Spend
—
Filings
38
Firms Hired
1
Active Period
2017–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Monitor general tax issues related to international tax, vaccine excise taxes and orphan drug tax issues. H.R. 1, One Big Beautiful Bill Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
American Rescue Plan Act of 2021
2022 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Policies impacting vaccine access and disease prevention. Prevention including provisions included in the Consolidated Appropriations Act, FY 23 (P.L. 117-328) related to pharmaceuticals.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1319
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Monitor general corporate tax issues. Issues related to vaccine excise taxes, and the Orphan Drug Tax Credit and interaction with other tax provisions; proposed changes to corporate and international taxation; H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169).
Client expense: — · Firm income: $50,000
Matched citations: H.R.5376
American Rescue Plan Act of 2021
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Policies impacting vaccine access and disease prevention.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1319
Lower Costs, More Cures Act of 2021
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement, Medicare Part D and Medicare Part B, and 340 B policies. Policies impacting public health preparedness and prevention, including vaccine development and vaccine administration. H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. H.R. 6833, Affordable Insulin Now Act. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 19
Lower Costs, More Cures Act of 2021
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. H.R. 6833, Affordable Insulin Now Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 19
Elijah E. Cummings Lower Drug Costs Now Act
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. H.R. 6833, Affordable Insulin Now Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3
Elijah E. Cummings Lower Drug Costs Now Act
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement, Medicare Part D and Medicare Part B, and 340 B policies. Policies impacting public health preparedness and prevention, including vaccine development and vaccine administration. H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. H.R. 6833, Affordable Insulin Now Act. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement, Medicare Part D and Medicare Part B, and 340 B policies. Policies impacting public health preparedness and prevention, including vaccine development and vaccine administration. H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. H.R. 6833, Affordable Insulin Now Act. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. H.R. 6833, Affordable Insulin Now Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Monitor general corporate tax issues. Issues related to vaccine excise taxes, and the Orphan Drug Tax Credit and interaction with other tax provisions; proposed changes to corporate and international taxation; H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169).
Client expense: — · Firm income: $50,000
Matched citations: H.R.5376
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement, Medicare Part D and Medicare Part B, and 340 B policies. Policies impacting public health preparedness and prevention, including vaccine development and vaccine administration. H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. H.R. 6833, Affordable Insulin Now Act. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6833
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about FDA approval policies and NIH research activities. H.R. 7667, the Food and Drug Amendments of 2022. S.4348, the FDA Safety and Landmark Act. H.R.6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180), including FDA User Fee Reauthorization Act of 2022.
Client expense: — · Firm income: $50,000
Matched citations: H.R.6833
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021 and H.R. 5376, "Inflation Reduction Act of 2022" (PL 117-169). Policies impacting U.S. address to the Covid-19 pandemic. H.R. 6833, Affordable Insulin Now Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6833
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about FDA approval policies and NIH research activities. H.R. 7667, the Food and Drug Amendments of 2022. S.4348, the FDA Safety and Landmark Act. H.R.6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180), including FDA User Fee Reauthorization Act of 2022.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7667
General education about FDA approval policies and NIH research activities. H.R. 7667, the Food and Drug Amendments of 2022. S.4348, the FDA Safety and Landmark Act. H.R.6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180), including FDA User Fee Reauthorization Act of 2022.
Client expense: — · Firm income: $50,000
Matched citations: S.4348
American Rescue Plan Act of 2021
2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Policies impacting vaccine access and disease prevention.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1319
Lower Costs, More Cures Act of 2021
2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement, Medicare Part D and Medicare Part B, and 340 B policies.. Policies impacting public health preparedness and prevention, including vaccine development and vaccine administration. H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021. Policies impacting U.S. address to the Covid-19 pandemic. H.R. 5376, Build Back Better Act. H.R. 6833, Affordable Insulin Now Act. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 19
Lower Costs, More Cures Act of 2021
2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021. Policies impacting U.S. address to the Covid-19 pandemic. H.R. 5376, Build Back Better Act. H.R. 6833, Affordable Insulin Now Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 19
Elijah E. Cummings Lower Drug Costs Now Act
2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about federal policies impacting pharmaceutical development, approval, and reimbursement, Medicare Part D and Medicare Part B, and 340 B policies.. Policies impacting public health preparedness and prevention, including vaccine development and vaccine administration. H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, Lower Costs, More Cures Act of 2021. Policies impacting U.S. address to the Covid-19 pandemic. H.R. 5376, Build Back Better Act. H.R. 6833, Affordable Insulin Now Act. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3
Source: Senate LDA